Neoadjuvant chemoradiotherapy followed by radical cystectomy for muscle-invasive bladder cancer: Efficacy and feasibility in 119 patients

被引:0
|
作者
Fujiwara, M. [1 ]
Tanaka, H. T. [1 ]
Asai, S. A. [1 ]
Maezawa, Y. M. [1 ]
Aida, Y. A. [1 ]
Chen, W. C. [1 ]
Yoshitomi, K. Y. [1 ]
Soma, T. S. [1 ]
Kobayashi, M. K. [1 ]
Nakamura, Y. N. [1 ]
Fan, B. F. [1 ]
Ishikawa, Y. I. [1 ]
Fukuda, S. F. [1 ]
Yoshida, S. Y. [1 ]
Yokoyama, M. Y. [1 ]
Fujii, Y. F. [1 ]
机构
[1] Tokyo Med & Dent Univ Grad Sch, Dept Urol, Tokyo, Japan
关键词
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
A1294
引用
收藏
页数:2
相关论文
共 50 条
  • [31] Cost-effectiveness of neoadjuvant chemotherapy before radical cystectomy for muscle-invasive bladder cancer
    Stevenson, Scott M.
    Danzig, Matthew R.
    Ghandour, Rashed A.
    Deibert, Christopher M.
    Decastro, G. Joel
    Benson, Mitchell C.
    McKiernan, James M.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2014, 32 (08) : 1172 - 1177
  • [32] Multicenter evaluation of neoadjuvant and induction gemcitabine–carboplatin versus gemcitabine–cisplatin followed by radical cystectomy for muscle-invasive bladder cancer
    Sarah M. H. Einerhand
    Anna J. Black
    Homayoun Zargar
    Adrian S. Fairey
    Colin P. Dinney
    Maria C. Mir
    Laura-Maria Krabbe
    Michael S. Cookson
    Niels-Erik Jacobson
    Jeffrey S. Montgomery
    Nikhil Vasdev
    Evan Y. Yu
    Evanguelos Xylinas
    Wassim Kassouf
    Marc A. Dall’Era
    Srikala S. Sridhar
    Jonathan S. McGrath
    Jonathan Aning
    Shahrokh F. Shariat
    Jonathan L. Wright
    Andrew C. Thorpe
    Todd M. Morgan
    Jeff M. Holzbeierlein
    Trinity J. Bivalacqua
    Scott North
    Daniel A. Barocas
    Yair Lotan
    Petros Grivas
    Jorge A. Garcia
    Andrew J. Stephenson
    Jay B. Shah
    Siamak Daneshmand
    Kamran Zargar-Shoshtari
    Philippe E. Spiess
    Bas W. G. van Rhijn
    Peter C. Black
    Laura S. Mertens
    World Journal of Urology, 2022, 40 : 2707 - 2715
  • [33] Postoperative weight loss followed by radical cystectomy predicts poor prognosis in patients with muscle-invasive bladder cancer
    Okita, Kazutaka
    Hatakeyama, Shingo
    Fujita, Naoki
    Konishi, Sakae
    Yamamoto, Hayato
    Imai, Atsushi
    Yoneyama, Takahiro
    Hashimoto, Yasuhiro
    Ito, Hiroyuki
    Yoshikawa, Kazuaki
    Koie, Takuya
    Ohyama, Chikara
    MEDICAL ONCOLOGY, 2019, 36 (01)
  • [34] Postoperative weight loss followed by radical cystectomy predicts poor prognosis in patients with muscle-invasive bladder cancer
    Kazutaka Okita
    Shingo Hatakeyama
    Naoki Fujita
    Sakae Konishi
    Hayato Yamamoto
    Atsushi Imai
    Takahiro Yoneyama
    Yasuhiro Hashimoto
    Hiroyuki Ito
    Kazuaki Yoshikawa
    Takuya Koie
    Chikara Ohyama
    Medical Oncology, 2019, 36
  • [35] Effects of neoadjuvant chemotherapy on pathological parameters and survival in patients undergoing radical cystectomy for muscle-invasive bladder cancer
    Caglayan, Alper
    Akbulut, Ziya
    Atmaca, Ali Fuat
    Altinova, Serkan
    Kilic, Metin
    Balbay, Mevlana Derya
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2012, 42 (04) : 623 - 629
  • [36] Survival outcomes of patients diagnosed with muscle-invasive bladder cancer who showed a response after neoadjuvant chemotherapy and refused radical cystectomy, and patients who had radical cystectomy or received chemoradiotherapy
    Tunc, Sezai
    Urakci, Zuhat
    Ebinc, Senar
    Ileri, Serdar
    Kalkan, Ziya
    Oruc, Zeynep
    Kucukoner, Mehmet
    Kaplan, Muhammet Ali
    Isikdogan, Abdurrahman
    ONCOLOGY IN CLINICAL PRACTICE, 2023, 19 (05): : 331 - 338
  • [37] Neoadjuvant chemotherapy for muscle-invasive bladder cancer: Complications and impact on cystectomy
    Neuzillet, Y.
    PROGRES EN UROLOGIE, 2015, 25 (09): : 555 - 556
  • [38] DELAYS IN CYSTECTOMY FOR PATIENTS WITH MUSCLE-INVASIVE BLADDER CANCER
    Chu, A.
    Holt, S.
    Gore, J.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2018, 66 (01) : 75 - 75
  • [39] Neoadjuvant sacituzumab govitecan, followed by radical cystectomy, for patients with muscle-invasive bladder cancer (MIBC): Updated interim results of SURE-01 trial
    Maiorano, B. A.
    Cigliola, A.
    Moschini, M.
    Tateo, V.
    Patane, D. A.
    Mercinelli, C.
    Nuccio, A.
    Latini, G.
    Borella, M.
    Brembilla, G.
    Colecchia, M.
    Montorsi, F.
    Necchi, A.
    ANNALS OF ONCOLOGY, 2024, 35 : S1510 - S1510
  • [40] A phase II study of neoadjuvant erlotinib in patients with muscle-invasive bladder cancer undergoing radical cystectomy: Preliminary results
    Kim, W. Y.
    Grigson, G. I.
    Wallen, E. M.
    Pruthi, R. S.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)